Literature DB >> 22732859

Bladder cancer: Pre-existing immunity to BCG can boost clinical response to intravesical therapy.

Sarah Payton.   

Abstract

Entities:  

Year:  2012        PMID： 22732859     DOI： 10.1038/nrurol.2012.132

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.

Authors:  Claire Biot; Cyrill A Rentsch; Joel R Gsponer; Frédéric D Birkhäuser; Hélène Jusforgues-Saklani; Fabrice Lemaître; Charlotte Auriau; Alexander Bachmann; Philippe Bousso; Caroline Demangel; Lucie Peduto; George N Thalmann; Matthew L Albert
Journal:  Sci Transl Med       Date:  2012-06-06       Impact factor: 17.956
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.